Insulin degludec has a two-fold longer half-life and a more consistent pharmacokinetic profile compared with insulin glargine
Year: 2012
Type: article
Source: Endocrine Abstracts
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W48115119
